These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16603535)

  • 61. Effects of blocking individual maturation cleavages in murine leukemia virus gag.
    Oshima M; Muriaux D; Mirro J; Nagashima K; Dryden K; Yeager M; Rein A
    J Virol; 2004 Feb; 78(3):1411-20. PubMed ID: 14722296
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Studies of human immunodeficiency virus type 1 (HIV-1) protease inhibitors. III. Structure-activity relationship of HIV-1 protease inhibitors containing cyclohexylalanylalanine hydroxyethylene dipeptide isostere.
    Sakurai M; Higashida S; Sugano M; Handa H; Komai T; Yagi R; Nishigaki T; Yabe Y
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):534-40. PubMed ID: 8004698
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells.
    Chen BK; Rousso I; Shim S; Kim PS
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15239-44. PubMed ID: 11742097
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases.
    Lin YC; Beck Z; Morris GM; Olson AJ; Elder JH
    J Virol; 2003 Jun; 77(12):6589-600. PubMed ID: 12767979
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors.
    Bally F; Martinez R; Peters S; Sudre P; Telenti A
    AIDS Res Hum Retroviruses; 2000 Sep; 16(13):1209-13. PubMed ID: 10957718
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Murine Leukemia Virus Glycosylated Gag Reduces Murine SERINC5 Protein Expression at Steady-State Levels via the Endosome/Lysosome Pathway to Counteract SERINC5 Antiretroviral Activity.
    Li S; Ahmad I; Shi J; Wang B; Yu C; Zhang L; Zheng YH
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355687
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.
    Lee SK; Nagashima K; Hu WS
    J Virol; 2005 Apr; 79(7):4159-69. PubMed ID: 15767417
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular and enzymatic characterization of the porcine endogenous retrovirus protease.
    Blusch JH; Seelmeir S; von der Helm K
    J Virol; 2002 Aug; 76(15):7913-7. PubMed ID: 12097607
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.
    Debouck C; Gorniak JG; Strickler JE; Meek TD; Metcalf BW; Rosenberg M
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8903-6. PubMed ID: 3321060
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of insertions in the HIV-1 p6 PTAPP region on the virological response to amprenavir.
    Lastere S; Dalban C; Collin G; Descamps D; Girard PM; Clavel F; Costagliola D; Brun-Vezinet F;
    Antivir Ther; 2004 Apr; 9(2):221-7. PubMed ID: 15134184
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
    Cimarelli A; Luban J
    J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structure and architecture of immature and mature murine leukemia virus capsids.
    Qu K; Glass B; Doležal M; Schur FKM; Murciano B; Rein A; Rumlová M; Ruml T; Kräusslich HG; Briggs JAG
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11751-E11760. PubMed ID: 30478053
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
    Kondo E; Mammano F; Cohen EA; Göttlinger HG
    J Virol; 1995 May; 69(5):2759-64. PubMed ID: 7707498
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Kinetics of Bovine leukemia virus aspartic protease reveals its dimerization and conformational change.
    Fló M; Carrión F; Olivero-Deibe N; Bianchi S; Portela M; Rammauro F; Alvarez B; Pritsch O
    PLoS One; 2022; 17(7):e0271671. PubMed ID: 35867649
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease.
    Menéndez-Arias L; Weber IT; Soss J; Harrison RW; Gotte D; Oroszlan S
    J Biol Chem; 1994 Jun; 269(24):16795-801. PubMed ID: 8207003
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Processing of gag precursor polyprotein of human T-cell leukemia virus type I by virus-encoded protease.
    Nam SH; Kidokoro M; Shida H; Hatanaka M
    J Virol; 1988 Oct; 62(10):3718-28. PubMed ID: 2843670
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro inhibition of HIV-1 proteinase by cerulenin.
    Moelling K; Schulze T; Knoop MT; Kay J; Jupp R; Nicolaou G; Pearl LH
    FEBS Lett; 1990 Feb; 261(2):373-7. PubMed ID: 1690152
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine.
    Baldwin ET; Bhat TN; Gulnik S; Liu B; Topol IA; Kiso Y; Mimoto T; Mitsuya H; Erickson JW
    Structure; 1995 Jun; 3(6):581-90. PubMed ID: 8590019
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of human immunodeficiency virus type 1 Pr55(Gag) and Pr160(Gag-pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitors.
    Speck RR; Flexner C; Tian CJ; Yu XF
    Antimicrob Agents Chemother; 2000 May; 44(5):1397-403. PubMed ID: 10770790
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria.
    Luban J; Lee C; Goff SP
    J Virol; 1993 Jun; 67(6):3630-4. PubMed ID: 8497070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.